The inclusion of tumor-unrelated and tumor-specific CD4+ T cell helper antigens in the neoantigen vaccines increased not only the frequency of vaccine-induced CD8+ T cells, but also altered their surface phenotype. This evidence concerns the gene CD8A and neoplasm.